CIK 0001041024
- Non-accelerated filer
- Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383317208
- Phone
- +1 800-449-3353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,420
- in 1 filing, $8K under 10b5-1 plans
Net −$8,420. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-06-13 | BOYD RONALD D Director | Other disposition · Stock option (right to buy) | −25,000 | 25,000 | ||
| 2013-06-13 | BOYD RONALD D Director | Other disposition · Stock option (right to buy) | −12,500 | 12,500 | ||
| 2013-06-13 | BOYD RONALD D Director | Other disposition · Stock option (right to buy) | −12,500 | 12,500 | ||
| 2013-06-13 | BOYD RONALD D Director | Other disposition · Stock option (right to buy) | −8,334 | 8,333 | ||
| 2013-06-13 | BOYD RONALD D Director | Other disposition · Stock option (right to buy) | −8,333 | 8,334 | ||
| 2013-06-13 | BOYD RONALD D Director | Other disposition · Stock option (right to buy) | −8,333 | 8,334 | ||
| 2013-02-08 | HOLT KENNETH L Director | Exercise or conversion | +25,000 | $3.06 | $77K | 32,900 |
| 2013-02-08 | HOLT KENNETH L Director | Shares withheld for taxes | −13,986 | $5.47 | $77K | 18,914 |
| 2013-02-08 | HOLT KENNETH L Director | Exercise or conversion | +10,000 | $4.05 | $41K | 28,914 |
| 2013-02-08 | HOLT KENNETH L Director | Shares withheld for taxes | −7,405 | $5.47 | $41K | 21,509 |
| 2013-02-08 | HOLT KENNETH L Director | Exercise or conversion · Stock option (right to buy) | −25,000 | 0 | ||
| 2013-02-08 | HOLT KENNETH L Director | Exercise or conversion · Stock option (right to buy) | −10,000 | 0 | ||
| 2013-01-31 | HOLT KENNETH L Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2013-01-31 | BOYD RONALD D Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2013-01-31 | Bagley Patrick J Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2013-01-31 | KLEMA THOMAS E Vice President, CFO | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2013-01-31 | Pratt Raymond Dennis VP of Drug Development | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2013-01-31 | Gupta Ajay Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2013-01-31 | CHIOINI ROBERT L Chairman, President and CEO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2013-01-28 | HAGELSTEIN DAVID A 10% owner | Other disposition · Common Stock Warrant | −862,502 | 0 |
Page 26 of 30 · 588 trades